newsfilter
← Latest News
GlobeNewswire·

Athenex to Participate in the 5th Annual Evercore ISI HealthCONx Conference

BUFFALO, N.Y., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer